Skip to main content
TipRanks
Go Ultimate75% OFF

Ultragenyx Pharmaceutical (RARE) Drug Pipeline

1 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Ux016Gne Myopathyphase1AndPhase2RecruitingFirst-in-human Study of UX016 in GNEMMar 30, 2026
No Intervention, Gtx-102Angelman SyndromePhase IIActive Not RecruitingA Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)Aug 21, 2025
SetrusumabOsteogenesis ImperfectaPhase IIIActive Not RecruitingSetrusumab in Pediatric Japanese Subjects With Osteogenesis ImperfectaOct 08, 2024―
Gtx-102, Sham-LpAngelman SyndromePhase IIIActive Not RecruitingPhase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)Sep 24, 2024―
Gtx-102Angelman SyndromePhase IIIActive Not RecruitingLong-term Extension of GTX-102 in Angelman SyndromeMay 10, 2024
Triheptanoin, Mct OilLong-Chain Fatty Acid Oxidation Disorders (Lc-Faod)Phase IIIActive Not RecruitingA Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAODJun 27, 2023―
Bisphosphonate, SetrusumabOsteogenesis ImperfectaPhase IIIActive Not RecruitingSetrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaMar 03, 2023―
Oral Corticosteroids, Dtx301, Sodium AcetateOtc DeficiencyPhase IIIActive Not RecruitingClinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) DeficiencyApr 18, 2022―
Oral Corticosteroids, Dtx401Glycogen Storage Disease Type IaPhase IIICompletedA Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)Jul 14, 2021
Standard Of Care, Ux701Wilson Diseasephase1AndPhase2Active Not RecruitingA Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson DiseaseMay 07, 2021―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Ultragenyx Pharmaceutical, Inc. (MX:RARE) have in its pipeline
Ultragenyx Pharmaceutical MX:RARE is currently developing the following drugs: Ux016, No Intervention, Gtx-102, Setrusumab, Gtx-102, Sham-Lp, Gtx-102, Triheptanoin, Mct Oil, Bisphosphonate, Setrusumab, Oral Corticosteroids, Dtx301, Sodium Acetate, Oral Corticosteroids, Dtx401, Standard Of Care, Ux701, Adjuvant Immunomodulatory Therapy, Ux111, Prophylactic Immunomodulatory Therapy, Optimized Prophylactic Im Therapy, Adjuvant Im Therapy. These drug candidates are in various stages of clinical development as the company works toward FDA approval.